Tadalafil for Treatment of Priapism in Men With Sickle Cell Anemia
Status:
Withdrawn
Trial end date:
2009-08-01
Target enrollment:
Participant gender:
Summary
This research is being done to compare the effect of tadalafil with placebo (an inactive
substance that looks like the study drug, but should have no effect) on the frequency of
recurrent priapism (prolonged erection, unassociated with sexual interest or desire) and the
nature of sexual experiences in male patients with sickle cell disease.